Mylan’s Plan to Copycat Botox Creates a Familiar Wrinkle for Allergan
Allergan Plc faces another risk after the generic drugmaker Mylan NV announced plans to align itself with a small-cap competitor and develop a biosimilar to Allergan’s top-selling wrinkle treatment and ...